Roth Capital Partners, a relationship-driven investment bank, has unveiled a comprehensive calendar of investor events scheduled from September 2026 through June 2027. The lineup includes seven ROTH-hosted conferences centered on key growth sectors such as healthcare, nuclear technology, solar and storage, and technology, along with sponsorship of several third-party events domestically and internationally.
The hosted events kick off with the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29 in New York, followed by the inaugural ROTH Critical Mass in Emerging Nuclear Technology on Oct. 1, also in New York. In November, the firm will host the 13th Annual ROTH Solar & Storage Symposium at RE+ from Nov. 16-18 in Las Vegas and the 15th Annual ROTH Technology Conference from Nov. 17-18 in New York. The calendar continues with the 15th Annual ROTH Deer Valley Event from Dec. 9-12 in Park City, Utah, the 39th Annual ROTH Conference from March 7-9, 2027, in Dana Point, California, and the 17th Annual ROTH London Conference from June 15-17, 2027.
In addition to hosting, Roth will sponsor select third-party events during the period, spanning cardiovascular technology, solar manufacturing, energy, medical innovation, and capital markets. The firm's involvement underscores its commitment to providing corporate access and investment insights across a broad spectrum of industries. Attendance at ROTH conferences is by invitation only, reflecting the firm's focus on fostering meaningful connections among institutional investors, corporate executives, and industry experts.
This extensive schedule indicates Roth's strategic emphasis on emerging technologies and high-growth sectors. The inclusion of a dedicated nuclear technology conference highlights the growing investor interest in advanced nuclear solutions as part of the clean energy transition. Similarly, the solar and storage symposium aligns with the continued expansion of renewable energy deployment and storage innovations. The healthcare and technology conferences address persistent demand for investment opportunities in biotech, medtech, and digital transformation.
Roth Capital Partners is headquartered in Newport Beach, California, and operates as a privately held, employee-owned firm with offices across the United States. Its full-service platform includes capital raising, equity research, sales and trading, and M&A advisory, among other services. By hosting these events, Roth aims to facilitate capital formation and provide its clients with access to cutting-edge investment themes.
The full calendar of events can be viewed at https://ibn.fm/qmNNA. For more information about Roth Capital Partners, visit www.roth.com.
